Rebif and Muscle spasticity - from FDA reports


Summary

Muscle spasticity is found among people who take Rebif, especially for people who are female, 50-59 old , have been taking the drug for 2 - 5 years, also take medication Baclofen, and have Multiple sclerosis . We study 45,935 people who have side effects while taking Rebif from FDA. Among them, 245 have Muscle spasticity. Find out below who they are, when they have Muscle spasticity and more.

What to expect?

If you take Rebif and have Muscle spasticity, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Rebif and have Muscle spasticity

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Rebif

Rebif has active ingredients of interferon beta-1a. It is often used in multiple sclerosis. (latest outcomes from Rebif 46,195 users)

Muscle Spasticity

Muscle spasticity (tight or stiff muscles and an inability to control those muscles) has been reported by people with multiple sclerosis, muscle spasticity, pain, depression, relapsing-remitting multiple sclerosis (latest reports from 23,415 Muscle spasticity patients).

On Jan, 31, 2017

45,935 people reported to have side effects when taking Rebif.
Among them, 245 people (0.53%) have Muscle Spasticity


Number of reports submitted per year:

Could Rebif cause Muscle spasticity?

Time on Rebif when people have Muscle Spasticity *:

  • < 1 month: 14.58 %
  • 1 - 6 months: 16.67 %
  • 6 - 12 months: 8.33 %
  • 1 - 2 years: 10.42 %
  • 2 - 5 years: 35.42 %
  • 5 - 10 years: 6.25 %
  • 10+ years: 8.33 %

Gender of people who have Muscle Spasticity when taking Rebif *:

  • female: 77.14 %
  • male: 22.86 %

Age of people who have Muscle Spasticity when taking Rebif *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 1.15 %
  • 20-29: 7.47 %
  • 30-39: 22.41 %
  • 40-49: 23.56 %
  • 50-59: 24.14 %
  • 60+: 21.26 %

Top conditions involved for these people *:

  • Multiple Sclerosis (176 people, 71.84%)
  • Relapsing-Remitting Multiple Sclerosis (24 people, 9.80%)
  • Depression (14 people, 5.71%)
  • Secondary Progressive Multiple Sclerosis (8 people, 3.27%)
  • Pain (7 people, 2.86%)

Top co-used drugs for these people *:

  • Baclofen (36 people, 14.69%)
  • Ibuprofen (19 people, 7.76%)
  • Tylenol (12 people, 4.90%)
  • Ampyra (11 people, 4.49%)
  • Fish Oil (10 people, 4.08%)

Top other side effects for these people *:

  • Weakness (43 people, 17.55%)
  • Fatigue (35 people, 14.29%)
  • Gait Disturbance (31 people, 12.65%)
  • Multiple Sclerosis Relapse (30 people, 12.24%)
  • Hypoaesthesia (30 people, 12.24%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Muscle spasticity when taking Rebif?

Browse all side effects of Rebif

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Muscle spasticity

Muscle spasticity

Could your condition cause Muscle spasticity

Muscle spasticity

Related studies

Can you answer these questions?

More questions for: Rebif, Muscle spasticity

You may be interested in these reviews

More reviews for: Rebif, Muscle spasticity